Clinical course of patients with major histocompatibility complex class II deficiency.
The clinical course of 10 children who have been diagnosed with major histocompatibility complex (MHC) class II deficiency (bare lymphocyte syndrome) in the UK over the past eight years is described. They have had a generally poor prognosis, with only two of the 10 still alive despite eight attempts at bone marrow transplantation in six patients. Overwhelming viral infection was the predominant cause of death. Alternative transplant strategies or novel therapies are required for these patients.
Saleem
M A
MA
The Hospital for Sick Children, Great Ormond St, London, WC1N 3JH, UK.
Arkwright
P D
PD
Davies
E G
EG
Cant
A J
AJ
Veys
P A
PA
D016026:Bone Marrow Transplantation; D005260:Female; D005500:Follow-Up Studies; D000949:Histocompatibility Antigens Class II / Q000097:blood*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D009894:Opportunistic Infections / Q000150:complications* / Q000276:immunology; D011379:Prognosis; D016511:Severe Combined Immunodeficiency / Q000150:complications* / Q000276:immunology / Q000628:therapy; D015996:Survival Rate; D014777:Virus Diseases / Q000150:complications / Q000276:immunology
D000949:Histocompatibility Antigens Class II